Chemung Financial Corp is a US-listed company in the regional banks industry. Its financial year ends in December.
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months to June 2026 was $120m, up 40.0% on a year earlier, faster than the 0.1% growth a quarter earlier. That growth ranks 17 of 190 among the regional banks companies we cover.
Our model value for Chemung Financial is under review, so past values are not shown until it is resolved.
Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Chemung Financial Corp's trailing-twelve-month revenue grew 40.0% year on year, with a free-cash-flow margin of 37.7%. Where it stands out: change in growth rate of +39.9pp ranks 1 of 244 regional banks companies we cover.
Current signal Revenue growth accelerating: TTM revenue growth rose to 40.0% (+39.9pp vs the prior quarter).
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
No model value for Chemung Financial Corp at the moment. Current status: valuation models disagree too widely to rate. Available reported financials are shown below.
The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.
We value Chemung Financial Corp as a bank or lender, with every model that fits that kind of business. Cost of equity 8%: the 10-year Treasury yield (4.9%) plus a beta of 0.68 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | ~$94 ~$65–$140 | Primary model, counts double |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | ~$100 ~$86–$130 | Included |
| Price-to-book vs return on equity (peers) The price-to-book that peers with this return on equity trade on, from a line fitted across peers. | ~$81 ~$50–$110 | Included |
| Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. | ~$45 ~$58–$87 | Included |
| Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. | ~$82 ~$77–$98 | Included |
| Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. | ~$110 ~$90–$140 | Included |
| Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. | — | Combined value withheld. Review the individual models and their assumptions. |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Chemung Financial Corp with banks and lenders in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Moderate moat
How hard Chemung Financial's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
Net income has been a median 0.9% of total assets over 10 years.
Net margin has been a median 25.4%; its worst year was 10.5%.
The diluted share count rose 2.4% over five years.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (59 before it).
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $8.42 | +45% | $125m | +32% |
| Next | $8.44 | +0% | $135m | +7% |
Next year's EPS estimate has moved +6.1% in 90 days, across 5 analysts.
The consensus EPS forecast for the current fiscal year is +11.3% on 90 days ago. In the last 30 days, 1 analyst raised Chemung Financial Corp's forecast and 0 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $7.57 | $7.95 |
| 60 days ago | $7.57 | $7.95 |
| 30 days ago | $7.61 | $8.17 |
| 7 days ago | $7.61 | $8.23 |
| Now | $8.42 | $8.44 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Sept 2026 | $1.96 | $2.63 | +34.5% |
| Jun 2026 | $1.76 | $1.82 | +3.1% |
| Mar 2026 | $1.63 | $1.91 | +17.5% |
| Dec 2025 | $1.61 | $1.61 | −0.3% |
Adjusted EPS as companies report it, against the average analyst estimate.
Last 12 months +76.2%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $86m | $120m | +40.0% |
| Net margin | 13.0% | 27.9% | +113.9% |
| P/E multiple | 21.2x | 12.6x | −40.7% |
| Share count | 5m | 5m | −0.7% |
Biggest factor: net margin.
Last 3 years +114.8%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $100m | $120m | +20.7% |
| Net margin | 27.5% | 27.9% | +1.3% |
| P/E multiple | 7.0x | 12.6x | +79.8% |
| Share count | 5m | 5m | −2.3% |
Biggest factor: p/e multiple.
| Calendar year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|---|---|
| Return | ||||||
| CHMG | +41% | +2% | +12% | +1% | +17% | +59% |
| Industry peers (median) | +34% | −4% | −2% | +16% | +10% | +24% |
| S&P 500 | +29% | −18% | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||||
| CHMG | 67% | 42% | 58% | 50% | 67% | 73% |
| S&P 500 | 75% | 42% | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||||
| CHMG | −10% | −14% | −35% | −21% | −24% | −21% |
| S&P 500 | −5% | −25% | −10% | −8% | −19% | −9% |
Worst fall since November 2, 2015: 55% from December 18, 2017 to March 16, 2020. Getting back needed a 123% gain, reached on August 2, 2022, 869 days after the low.
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| October 22, 2026 | +2.7% | −1.7% | +7.3% | — |
| July 22, 2026 | −2.8% | −1.3% | +6.6% | +7.8% |
| April 17, 2026 | +14.6% | +1.0% | +12.7% | +11.7% |
| January 26, 2026 | +4.1% | +0.9% | +8.7% | +1.2% |
| October 21, 2025 | +1.3% | −0.5% | +1.3% | −1.0% |
| July 17, 2025 | +0.2% | +0.5% | +1.1% | −2.6% |
| April 18, 2025 | −0.9% | −2.4% | +1.8% | +13.1% |
| January 28, 2025 | +15.5% | +0.4% | +8.5% | +10.1% |
| October 22, 2024 | 0.0% | −1.0% | −0.2% | +6.2% |
| July 18, 2024 | −2.9% | −1.4% | −3.8% | −10.5% |
| April 18, 2024 | +9.3% | −1.1% | +9.3% | +9.1% |
| January 25, 2024 | +0.3% | +0.4% | −7.2% | −13.6% |
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | Revenue (TTM) |
|---|---|
| FY23 Q3 | $101.5M |
| FY23 Q4 | $99M |
| FY24 Q1 | $97.4M |
| FY24 Q2 | $96.7M |
| FY24 Q3 | $95.2M |
| FY24 Q4 | $97.3M |
| FY25 Q1 | $99.2M |
| FY25 Q2 | $86M |
| FY25 Q3 | $90.5M |
| FY25 Q4 | $95.1M |
| FY26 Q1 | $99.3M |
| FY26 Q2 | $120.4M |
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY23 Q3 | 10.3% |
| FY23 Q4 | 3.5% |
| FY24 Q1 | -1.3% |
| FY24 Q2 | -3.0% |
| FY24 Q3 | -6.2% |
| FY24 Q4 | -1.7% |
| FY25 Q1 | 1.9% |
| FY25 Q2 | -11.1% |
| FY25 Q3 | -5.0% |
| FY25 Q4 | -2.2% |
| FY26 Q1 | 0.1% |
| FY26 Q2 | 40.0% |
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | FCF margin (TTM) |
|---|---|
| FY23 Q3 | 28.7% |
| FY23 Q4 | 30.7% |
| FY24 Q1 | 28.6% |
| FY24 Q2 | 27.2% |
| FY24 Q3 | 26.8% |
| FY24 Q4 | 26.9% |
| FY25 Q1 | 25.4% |
| FY25 Q2 | 33.8% |
| FY25 Q3 | 35.8% |
| FY25 Q4 | 46.1% |
| FY26 Q1 | 46.2% |
| FY26 Q2 | 37.7% |
What Chemung Financial earned on its loans and securities in FY2025, what it paid depositors and lenders, and how its revenue split between running costs, credit losses, tax and profit.
| Interest income | $133M | |
|---|---|---|
| Fee and other income | $7.9M | 8.4% of revenue |
| Interest paid | $45.7M | |
| Net interest income | $87.2M | 91.6% of revenue |
| Revenue | $95.1M | |
| Non-interest expense | $70.7M | 74.4% of revenue |
| Credit-loss provisions | $4.4M | 4.7% of revenue |
| Pre-tax profit | $19.9M | 21.0% of revenue |
| Income tax | $4.8M | 5.1% of revenue |
| Net income | $15.1M | 15.9% of revenue |
| Fiscal year | 2009 Dec 2009 | 2010 Dec 2010 | 2011 Dec 2011 | 2012 Dec 2012 | 2013 Dec 2013 | 2014 Dec 2014 | 2015 Dec 2015 | 2016 Dec 2016 | 2017 Dec 2017 | 2018 Dec 2018 | 2019 Dec 2019 | 2020 Dec 2020 | 2021 Dec 2021 | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 | LTM Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||
| Revenue | 49 | 54 | 61 | 64 | 65 | 76 | 71 | 73 | 77 | 84 | 81 | 84 | 89 | 96 | 99 | 97 | 95 | 120 |
| Net income | 5 | 10 | 11 | 11 | 9 | 8 | 9 | 10 | 7 | 20 | 16 | 19 | 26 | 29 | 25 | 24 | 15 | 34 |
| Diluted EPS | — | — | $2.40 | $2.38 | $1.87 | $1.74 | $2.00 | $2.11 | $1.55 | $4.06 | $3.21 | $4.01 | $5.64 | $6.13 | $5.28 | $4.96 | $3.14 | $6.96 |
| Growth (year on year) | ||||||||||||||||||
| Revenue | — | +10.9% | +13.3% | +4.3% | +1.1% | +18.0% | −6.9% | +3.4% | +5.4% | +7.8% | −3.4% | +4.2% | +6.4% | +6.9% | +3.5% | −1.7% | −2.2% | +40.0% |
| Net income | — | +93.0% | +4.3% | +4.6% | −20.8% | −6.6% | +15.6% | +6.3% | −25.9% | +164.1% | −20.5% | +23.4% | +37.2% | +8.9% | −13.1% | −5.3% | −36.2% | +199.3% |
| Diluted EPS | — | — | — | −0.8% | −21.4% | −7.0% | +14.9% | +5.5% | −26.5% | +161.9% | −20.9% | +24.9% | +40.6% | +8.7% | −13.9% | −6.1% | −36.7% | +197.3% |
| Margins | ||||||||||||||||||
| Net margin | 10.7% | 18.6% | 17.2% | 17.2% | 13.5% | 10.7% | 13.3% | 13.6% | 9.6% | 23.5% | 19.3% | 22.9% | 29.5% | 30.1% | 25.3% | 24.3% | 15.9% | 27.9% |
| Free-cash-flow margin | 14.0% | 29.1% | 10.8% | 32.6% | 29.8% | 20.8% | 18.2% | 27.8% | 28.6% | 31.1% | 31.6% | 33.1% | 39.2% | 36.2% | 30.7% | 26.9% | 46.1% | 37.7% |
| Cash flow | ||||||||||||||||||
| Cash from operations | 9 | 18 | 9 | 25 | 23 | 18 | 14 | 22 | 24 | 28 | 26 | 29 | 35 | 35 | 31 | 30 | 45 | 47 |
| Capital spending | 2 | 2 | 3 | 4 | 4 | 3 | 1 | 2 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 4 | 2 | 1 |
| Free cash flow | 7 | 16 | 7 | 21 | 19 | 16 | 13 | 20 | 22 | 26 | 26 | 28 | 35 | 35 | 30 | 26 | 44 | 45 |
| Balance sheet | ||||||||||||||||||
| Cash | 80 | 61 | 53 | 40 | 52 | 29 | 26 | 74 | 31 | 130 | 122 | 109 | 27 | 56 | 37 | 47 | 50 | 73 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 131 | 134 |
| Net debt (negative = net cash) | −80 | −61 | −53 | −40 | −52 | −29 | −26 | −74 | −31 | −130 | −122 | −109 | −27 | −56 | −37 | −47 | 81 | 61 |
| Diluted shares | 4m | 4m | 4m | 5m | 5m | 5m | 5m | 5m | 5m | 5m | 5m | 5m | 5m | 5m | 5m | 5m | 5m | 5m |
| Returned to shareholders | ||||||||||||||||||
| Dividends | 4 | 4 | 4 | 6 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 6 | 7 |
| Buybacks | 0 | 0 | 1 | 1 | 0 | 0 | 0 | — | — | 0 | 0 | 8 | 2 | 1 | 0 | 0 | 0 | 0 |
| Total returned | 4 | 4 | 5 | 6 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 13 | 7 | 7 | 6 | 8 | 7 | 7 |
| Quarter | 2024 Q3 Sept 2024 | 2024 Q4 Dec 2024 | 2025 Q1 Mar 2025 | 2025 Q2 Jun 2025 | 2025 Q3 Sept 2025 | 2025 Q4 Dec 2025 | 2026 Q1 Mar 2026 | 2026 Q2 Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | 24 | 26 | 26 | 10 | 29 | 31 | 30 | 31 |
| Net income | 6 | 6 | 6 | −6 | 8 | 8 | 9 | 9 |
| Diluted EPS | $1.19 | $1.24 | $1.26 | −$1.35 | $1.62 | $1.61 | $1.91 | $1.82 |
| Growth (year on year) | ||||||||
| Revenue | −5.9% | +8.9% | +8.3% | −56.7% | +18.4% | +17.9% | +16.3% | +208.6% |
| Net income | −25.2% | +55.5% | −14.6% | −229.4% | +36.2% | +30.9% | +52.7% | — |
| Diluted EPS | −26.1% | +55.0% | −14.9% | −228.6% | +36.1% | +29.8% | +51.6% | — |
| Margins | ||||||||
| Net margin | 23.5% | 22.9% | 23.4% | −63.9% | 27.1% | 25.4% | 30.8% | 28.3% |
| Free-cash-flow margin | 35.2% | 16.7% | 26.7% | 92.9% | 41.1% | 51.6% | 29.8% | 28.6% |
| Cash flow | ||||||||
| Cash from operations | 9 | 6 | 7 | 10 | 12 | 16 | 9 | 9 |
| Capital spending | 1 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
| Free cash flow | 9 | 4 | 7 | 9 | 12 | 16 | 9 | 9 |
| Last 12 months unless stated | CHMG | PCB | PDLB | ISTR | BWFG | CZFS | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $120m | $120m | $120m | $120m | $122m | $118m | $255m |
| Revenue growth, last 12 months | 40.0% | 11.8% | 27.6% | 30.5% | 31.6% | 12.5% | 12.5% |
| Revenue growth, 3-year average | 6.5% | 5.1% | 19.3% | 8.5% | 5.1% | 12.2% | 6.0% |
| Revenue growth, latest quarter | 208.6% | 4.8% | 19.3% | 65.2% | 26.3% | 8.8% | 10.7% |
| Net margin | 27.9% | 34.7% | 28.1% | 28.1% | 35.2% | 34.8% | 28.7% |
| Cash from operations / revenue | 38.9% | 34.3% | 48.5% | 22.5% | 29.4% | 31.8% | 34.3% |
| Free-cash-flow margin | 37.7% | 33.9% | 48.0% | 19.1% | 28.3% | 31.2% | 31.4% |
| Free-cash-flow margin, 3-year average | 32.9% | 34.0% | 26.6% | 17.5% | 28.0% | 33.2% | 29.9% |
| Stock pay / revenue | — | 0.8% | 1.9% | 1.7% | 2.8% | — | 1.2% |
| Change in share count | 0.7% | −1.1% | 2.2% | 36.1% | 1.4% | −0.3% | 0.4% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 40.0% | 12.5% | 17 of 245 |
| Change in growth rate Growth | +39.9pp | +0.0pp | 1 of 244 |
| Net margin Profitability | 27.9% | 28.7% | 136 of 245 |
| Change in share count Balance sheet | 0.7% | 0.4% | 135 of 230 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Line of business | Revenue | YoY |
|---|---|---|
| Wealth Management Group Services | $11.9M | ▲ 3.2% |
| WMG Fee Income | $11.9M | ▲ 3.2% |
| Service Chargeon Deposits | $4.4M | ▲ 9.5% |
| Interchange Revenue | $4.3M | ▼ 2.8% |
| Overdraft Fees | $2.9M | ▼ 4.5% |
| Service Chargeon Deposits Other | $1.6M | ▲ 49.8% |
| Investment Brokerage | $1.2M | ▲ 11.6% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Chemung Financial Corp's 10-K filed March 13, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Blackrock, Inc. | $29.2M | 391K | 16.4% | ▲ 8.2% |
| Chemung Canal Trust Co | $21.2M | 285K | 11.9% | ▼ 0.5% |
| Dimensional Fund Advisors LP | $13.9M | 187K | 7.8% | ▲ 2.6% |
| Vanguard Capital Management LLC | $12.3M | 164K | 6.9% | ▼ 5.1% |
| Manufacturers Life Insurance Company, The | $12.1M | 162K | 6.8% | ▲ 2.9% |
| Pl Capital Advisors, LLC | $8.2M | 109K | 4.6% | 0.0% |
| Geode Capital Management, LLC | $7.3M | 98K | 4.1% | ▲ 8.4% |
| Acadian Asset Management LLC | $7.1M | 95K | 4.0% | ▲ 20.8% |
| State Street Corp | $5M | 67K | 2.8% | ▲ 15.9% |
| Renaissance Technologies LLC | $4.5M | 61K | 2.5% | ▲ 47.2% |
| Bridgeway Capital Management, LLC | $4M | 53K | 2.2% | ▲ 1.8% |
| Goldman Sachs Group Inc | $2.9M | 39K | 1.6% | ▼ 5.8% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Chemung Financial Corp's complete shareholder register. Values are as reported by the filers .
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Next expected around January 25, 2027 estimated from the company's past filing pattern, not announced
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
